Cargando…
Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes
To test the clinical relevance of monoclonal anti-I-A antibody in autoimmune disease, we investigated the effects of such a therapy in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) by instituting treatment after the onset of paralytic signs and following the clinical cour...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187382/ https://www.ncbi.nlm.nih.gov/pubmed/6194246 |
Ejemplares similares
-
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
por: DuBois, Juwen C., et al.
Publicado: (2020) -
Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020) -
Monoclonal antibody against an Ir gene product?
Publicado: (1980) -
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Clemente, Nausicaa, et al.
Publicado: (2017) -
A major anti-myoglobin idiotype. Influence of H-2-linked Ir genes on idiotype expression
Publicado: (1984)